Sphingosine kinase type 1 inhibitors and uses thereof
US10166204B2 · kind B2 · utility
3Cited by
7References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2018 |
| Grant date | Jan 1, 2019 |
| Priority date | — |
| Expiry date | Apr 16, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/092
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are inhibitors of sphingosine kinase Type I that are useful in a number of applications, indications and diseases, as well as for monitoring pharmacokinetics and patient management. These compounds are applicable to treating tumors of the central nervous system, such as glioblastoma multiforme (GBM).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.